Press Release – New York, NY – February 27, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL.TA), an Israeli …
Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc.
Press Release – New York, NY – June 8, 2017 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it has represented Joseph Gunnar & …
Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co. and Brookline Capital Markets in a $13.25 PIPE for MRI Interventions, Inc.
Press Release – New York, NY – May 26, 2017 - Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC, as lead Placement Agent and Brookline Capital …
Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down
Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals …
Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.
Press Release – New York, NY – March 22, 2017 - Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd. (“XTLB. NASDAQ”), an Israeli biopharmaceutical …
Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering
Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation …
